Not all people with CLL need therapy. Inspite of all modern advances, the iwCLL nevertheless recommends watchful observation for patients with asymptomatic ailment.86 This recommendation relies on at the least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). ddbola selalu memberikan promosi dan https://maryh208gpy8.mybuzzblog.com/profile